| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Comm &Medical Affairs | SVP, Comm &Medical Affairs
1 company
Farnum Rhonda is a SVP, Comm &Medical Affairs at TBPH. Recent filings cover 0 purchases and 24 sales.
Our model assigns Farnum Rhonda a middling insider score of 51/100, based on 14 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -24.9%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 13,314 | $17.03 | $226,793.34 | -5.9% | - | - | |
| Jun 15, 2026 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 13,314 | $16.39 | $218,167.20 | -5.4% | +4.4% | - | |
| Dec 3, 2025 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 31,067 | $18.75 | $582,500.81 | -10.1% | -26.1% | - | |
| Jul 14, 2025 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 10,000 | $11.39 | $113,869.51 | -3.0% | +21.4% | +47.6% | |
| Jun 2, 2025 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 24,000 | $11.00 | $264,000.00 | -6.6% | +24.1% | +44.0% | |
| Apr 21, 2025 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 4,000 | $9.00 | $36,000.00 | -1.1% | +24.3% | - | |
| Jan 21, 2025 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 4,000 | $9.00 | $36,000.00 | -1.3% | -0.2% | +122.6% | |
| Nov 11, 2024 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 4,000 | $9.00 | $36,000.00 | -1.2% | +0.4% | +103.7% | |
| Jul 10, 2024 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 4,000 | $9.00 | $36,000.00 | -1.2% | -10.1% | +29.9% | |
| Feb 22, 2024 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 1,254 | $8.71 | $10,922.34 | -0.4% | +3.5% | +7.4% |